Abstract
CYCLIC NUCLEOTIDES mediate many aspects of normal cellular metabolism1; thus, degradation as well as synthesis of these intracellular mediators must be strictly regulated. Phosphodiesterase (PDE), the enzyme of cyclic nucleotide catabolism, is present in mammalian tissues in multiple forms, which differ in substrate specificity, kinetic characteristics and sub-cellular localisation2. Moreover, a calcium-dependent protein activator (now called calmodulin) has been characterised that specifically activates at least one of the PDE types3,4 although other types of PDE are known to be activator independent5,6. Thus, several mechanisms are present in vivo which allow strict control of PDE. A unique cyclic GMP-PDE is compartmentalised in the outer segments of retinal photoreceptor cells7–10; its activity is low in the dark-adapted state but increases dramatically on light adaptation10–12. The resulting drop in cyclic GMP content could serve as a chemical ‘signal’ in the normal visual process13,14. However, despite much investigation of various cyclic nucleotide systems, no definitive information has been obtained which clearly links a disorder of cyclic nucleotide metabolism with a disease process elsewhere than in retina15,16. We have recently presented preliminary evidence that an abnormality in cyclic GMP metabolism could be present in the retinas of Irish setter dogs with inherited rod–cone dysplasia15 that could lead to greatly increased cyclic GMP content, as had been reported in mice with inherited retinal degeneration16. We now report that the basic defect in the disease seems to be a failure to switch PDE type and a concomitant decrease in protein activator concentration early in postnatal development, at the time of photoreceptor differentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Robinson, G., Butcher, R. & Sutherland, E. A. Rev. Biochem. 37, 149–163 (1968).
Appleman, M. & Terasaki, W. Adv. Cyclic Nucleotide Res. 5, 153–162 (1975).
Cheung, W. Biochem. biophys. Res. Commun. 29, 478–482 (1967).
Kakiuchi, S. & Yamazaki, R. Biochem. biophys. Res. Commun. 41, 1104–1110 (1970).
Uzunov, P. & Weiss, B. Biochim. biophys. Acta 284, 220–226 (1972).
Liu, Y. & Schwartz, H. Biochim. biophys. Acta 526, 186–193 (1978).
Chader, G., Johnson, M., Fletcher, R. & Bensinger, R. J. Neurochem. 22, 93–99 (1974).
Orr, H., Lowry, O., Cohen, A. & Ferrendelli, J. Proc. natn. Acad. Sci. U.S.A. 73, 4442–4445 (1976).
Farber, D. & Lolley, R. J. Neurochem. 28, 1089–1095 (1977).
Bitensky, M. et al. Adv. Cyclic Nucleotide Res. 5, 213–239 (1975).
Chader, G., Herz, L. & Fletcher, R. Biochim. biophys. Acta 347, 491–493 (1974).
Yee, R. & Liebman, P. J. biol. Chem. 253, 8902–8909 (1978).
Goridis, C., Virmaux, N., Cailla, H. & Delaage, M. FEBS Lett. 49, 167–169 (1974).
Fletcher, R. & Chader, G. Biochem. biophys. Res. Commun. 70, 1297–1302 (1976).
Aguirre, G., Farber, D., Lolley, R., Fletcher, R. & Chader, G. Science 201, 1133–1134 (1978).
Farber, D. & Lolley, R. Science 186, 449–451 (1974).
Lowry, O., Rosebrough, N., Farr, A. & Randall, R. J. biol. Chem. 193, 265–275 (1951).
Lin, Y., Liu, Y. & Cheung, W. J. biol. Chem. 249, 4943–4954 (1974).
Hebel, R. Adv. Anat. Embryol. Cell Biol. 45, 1–92 (1971).
Teo, T. & Wang, J. J. biol. Chem. 248, 5950–5955 (1973).
Liu, Y. & Cheung, W. J. biol. Chem. 251, 4193–4198 (1976).
Kakiuchi, S., Yamazaki, R., Teshima, Y. & Uenishi, K. Proc. natn. Acad. Sci. U.S.A. 70, 3526–3531 (1973).
Villee, C. Fedn Proc. 25, 874–878 (1966).
Greengard, O. & Thorndike, J. Enzyme 17, 333–378 (1974).
Tanigawa, Y., Shimoyama, M., Tai, J., Fujii, K. & Veda, I. Biochem. biophys. Res. Commun. 73, 19–24 (1976).
Singer, A., Dunn, A. & Appleman, M. Archs Biochem. Biophys. 187, 406–413 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LIU, Y., KRISHNA, G., AGUIRRE, G. et al. Involvement of cyclic GMP phosphodiesterase activator in an hereditary retinal degeneration. Nature 280, 62–64 (1979). https://doi.org/10.1038/280062a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/280062a0
This article is cited by
-
Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy
Molecular Therapy (2012)
-
Animal models of human retinal dystrophies
Eye (1998)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.